IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Assertio Therapeutics Inc (DEPOEUR)

CUSIP: 04545L107 | XS | 247 institutional holders

Quarters

Q2 2024Q3 2020Q2 2020Q1 2020Q4 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

AlphaMark Advisors, LLC37
0.0% of portfolio›$0
StyleTurnoverLocationFiled
AlphaMark Advisors, LLC
37$00.0%GrowthVery LowFort Mitchell, KY2024-07-17